Ethical considerations in the management of amyotrophic lateral sclerosis

Progress in Neurobiology

Volumn 110, Issue , 2013, Pages 45-53

  Eisen, Andrew ^a   Krieger, Charles ^a,b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

^c Strong Rehab Centre   (Canada)

Author keywords

Amyotrophic lateral sclerosis; Ethics; Familial amyotrophic lateral sclerosis; Gastrostomy; Permanent ventilation; Ventilation

Indexed keywords

C9ORF72 PROTEIN; CHOLESTANETRIOL 26 MONOOXYGENASE; LOCAL ANESTHETIC AGENT; MICROTUBE ASSOCIATED PROTEIN TAU GENE; PROGRANULIN; PROTEIN; SEDATIVE AGENT; UNCLASSIFIED DRUG;

ALTERNATIVE MEDICINE; AMYOTROPHIC LATERAL SCLEROSIS; ASSISTED SUICIDE; ASSISTED VENTILATION; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; CONSCIOUS SEDATION; CULTURAL FACTOR; FAMILY ATTITUDE; FRONTOTEMPORAL DEMENTIA; GASTROSTOMY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; HUMAN; INFORMATION DISSEMINATION; LOCAL ANESTHESIA; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICAL INFORMATION; NONINVASIVE VENTILATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STEM CELL TRANSPLANTATION; TERMINAL CARE;

ALS; AMYOTROPHIC LATERAL SCLEROSIS; C9 OPEN READING FRAME 72; C9ORF72; ETHICS; FALS; FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS; FRONTO-TEMPORAL DEMENTIA; FRONTO-TEMPORAL LOBAR DEMENTIA; FTD; FTLD; GASTROSTOMY; PEG; PER-ORAL IMAGE-GUIDED GASTROSTOMY; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PERMANENT VENTILATION; PIG; PRGN; PROGRANULIN; RADIOLOGICALLY INSERTED GASTROSTOMY; RIG; SALS; SOD; SPORADIC ALS; SUPEROXIDE DISMUTASE 1; VENTILATION;

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL TRIALS AS TOPIC; COGNITION DISORDERS; EMPLOYMENT; GENETIC TESTING; HUMANS; PATIENT CARE MANAGEMENT;

EID: 84886789697     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2013.05.001     Document Type: Review

References (84)

1. Abdelnour-Mallet M., Verschueren A., Guy N., Soriani M.H., Chalbi M., Gordon P., Salachas F., Bruneteau G., le Forestier N., Lenglet T., Desnuelle C., Clavelou P., Pouget J., Meininger V., Pradat P.F. Safety of home parenteral nutrition in patients with amyotrophic lateral sclerosis: a French national survey. Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2011, 12:178-184.
2. Achille M.A., Ogloff J.R. Attitudes toward and desire for assisted suicide among persons with amyotrophic lateral sclerosis. Omega 2003, 48:1-21.
3. Al-Chalabi A., Andersen P.M., Chioza B., Shaw C., Sham P.C., Robberecht W., Matthijs G., Camu W., Marklund S.L., Forsgren L., Rouleau G., Laing N.G., Hurse P.V., Siddique T., Leigh P.N., Powell J.F. Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor. Human Molecular Genetics 1998, 7:2045-2050.
4. Al-Chalabi A., Jones A., Troakes C., King A., Al-Sarraj S., van den Berg L.H. The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathologica 2012, 124:339-352.
5. Andersen P.M., Borasio G.D., Dengler R., Hardiman O., Kollewe K., Leigh P.N., Pradat P.F., Silani V., Tomik B., Diagnosis E.T.F.o., Management of Amyotrophic Lateral S. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. European Journal of Neurology 2005, 12:921-938.
6. Andersen P.M., Spitsyn V.A., Makarov S.V., Nilsson L., Kravchuk O.I., Bychkovskaya L.S., Marklund S.L. The geographical and ethnic distribution of the D90A CuZn-SOD mutation in the Russian Federation. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases 2001, 2:63-69.
7. Aoki M., Warita H., Suzuki N., Kato M. Clinical genetics of amyotrophic lateral sclerosis in Japan: an update. Clinical Neurology 2012, 52:844-847.
8. Atassi N., Cook A., Pineda C.M., Yerramilli-Rao P., Pulley D., Cudkowicz M. Depression in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2011, 12:109-112.
9. Baumann F., Henderson R.D., Morrison S.C., Brown M., Hutchinson N., Douglas J.A., Robinson P.J., McCombe P.A. Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2010, 11:194-202.
10. Baumrucker S.J., Carter G., Morris G.M., Stolick M., Sheldon J.E., Brothers D. Amyotrophic lateral sclerosis and physician assisted suicide. The American Journal of Hospice & Palliative Care 2006, 23:332-337.
11. Borasio G.D., Sloan R., Pongratz D.E. Breaking the news in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 1998, 160(Suppl 1):S127-S133.
12. Bourke S.C., O'Neill C.L., Williams T.L., Peel E.T., Gibson G.J., McDermott C.J., Shaw P.J. The changing landscape of non-invasive ventilation in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry 2012, 83:368-369.
13. Bourke S.C., Tomlinson M., Williams T.L., Bullock R.E., Shaw P.J., Gibson G.J. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurology 2006, 5:140-147.
14. Charles C., Whelan T., Gafni A. What do we mean by partnership in making decisions about treatment?. British Medical Journal 1999, 319:780-782.
15. Chio A., Borasio G.D. Breaking the news in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases 2004, 5:195-201.
16. Chio A., Calvo A., Moglia C., Gamna F., Mattei A., Mazzini L., Mora G. Non-invasive ventilation in amyotrophic lateral sclerosis: a 10 year population based study. Journal of Neurology, Neurosurgery, and Psychiatry 2012, 83:377-381.
17. Cudkowicz M.E., Katz J., Moore D.H., O'Neill G., Glass J.D., Mitsumoto H., Appel S., Ravina B., Kieburtz K., Shoulson I., Kaufmann P., Khan J., Simpson E., Shefner J., Levin B., Cwik V., Schoenfeld D., Aggarwal S., McDermott M.P., Miller R.G. Toward more efficient clinical trials for amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2010, 11:259-265.
18. Danel-Brunaud V., Laurier L., Parent K., Moreau C., Defebvre L., Jacquemin D., Destee A. Issues of France's Leonetti Act: involvement of amyotrophic lateral sclerosis patients in prior discussions concerning respiratory support and end-of-life care. Revue Neurologique 2009, 165:170-177.
19. Diekstra F.P., Saris C.G., van Rheenen W., Franke L., Jansen R.C., van Es M.A., van Vught P.W., Blauw H.M., Groen E.J., Horvath S., Estrada K., Rivadeneira F., Hofman A., Uitterlinden A.G., Robberecht W., Andersen P.M., Melki J., Meininger V., Hardiman O., Landers J.E., Brown R.H., Shatunov A., Shaw C.E., Leigh P.N., Al-Chalabi A., Ophoff R.A., van den Berg L.H., Veldink J.H. Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS. PloS ONE 2012, 7:e35333.
20. Dreyer P.S., Felding M., Klitnaes C.S., Lorenzen C.K. Withdrawal of invasive home mechanical ventilation in patients with advanced amyotrophic lateral sclerosis: ten years of Danish experience. Journal of Palliative Medicine 2012, 15:205-209.
21. Egede-Nissen V., Jakobsen R., Sellevold G.S., Sorlie V. Time ethics for persons with dementia in care homes. Nursing Ethics 2013, 20:51-60.
22. Eisen A., Mezei M.M., Stewart H.G., Fabros M., Gibson G., Andersen P.M. SOD1 gene mutations in ALS patients from British Columbia, Canada: clinical features, neurophysiology and ethical issues in management. Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2008, 9:108-119.
23. Fanos J.H., Gronka S., Wuu J., Stanislaw C., Andersen P.M., Benatar M. Impact of presymptomatic genetic testing for familial amyotrophic lateral sclerosis. Genetics in Medicine: Official Journal of the American College of Medical Genetics 2011, 13:342-348.
24. Felbecker A., Camu W., Valdmanis P.N., Sperfeld A.D., Waibel S., Steinbach P., Rouleau G.A., Ludolph A.C., Andersen P.M. Four familial ALS pedigrees discordant for two SOD1 mutations: are all SOD1 mutations pathogenic?. Journal of Neurology, Neurosurgery, and Psychiatry 2010, 81:572-577.
25. Flores Y.G., Hinton L., Barker J.C., Franz C.E., Velasquez A. Beyond familism: a case study of the ethics of care of a Latina caregiver of an elderly parent with dementia. Health Care for Women International 2009, 30:1055-1072.
26. Furukawa Y., Komai K., Ishida C., Takahashi K., Tagami A., Motozaki Y., Ikeda T. Cause of death in Japanese patients with amyotrophic lateral sclerosis on tracheostomy-positive pressure ventilation. European Neurology 2012, 68:261-263.
27. Gagliardi S., Cova E., Davin A., Guareschi S., Abel K., Alvisi E., Laforenza U., Ghidoni R., Cashman J.R., Ceroni M., Cereda C. SOD1 mRNA expression in sporadic amyotrophic lateral sclerosis. Neurobiology of Disease 2010, 39:198-203.
28. Garcia-Redondo A., Dols-Icardo O., Rojas-Garcia R., Esteban-Perez J., Cordero-Vazquez P., Munoz-Blanco J.L., Catalina I., Gonzalez-Munoz M., Varona L., Sarasola E., Povedano M., Sevilla T., Guerrero A., Pardo J., de Munain A.L., Marquez-Infante C., de Rivera F.J., Pastor P., Jerico I., de Arcaya A.A., Mora J.S., Clarimon J., Gonzalo-Martinez J.F., Juarez-Rufian A., Atencia G., Jimenez-Bautista R., Moran Y., Mascias J., Hernandez-Barral M., Kapetanovic S., Garcia-Barcina M., Alcala C., Vela A., Ramirez-Ramos C., Galan L., Perez-Tur J., Quintans B., Sobrido M.J., Fernandez-Torron R., Poza J.J., Gorostidi A., Paradas C., Villoslada P., Larrode P., Capablo J.L., Pascual-Calvet J., Goni M., Morgado Y., Guitart M., Moreno-Laguna S., Rueda A., Martin-Estefania C., Cemillan C., Blesa R., Lleo A. Analysis of the C9ORF72 gene in patients with amyotrophic lateral sclerosis in Spain and different populations worldwide. Human Mutation 2013, 34:79-82.
29. Huey E.D., Grafman J., Wassermann E.M., Pietrini P., Tierney M.C., Ghetti B., Spina S., Baker M., Hutton M., Elder J.W., Berger S.L., Heflin K.A., Hardy J., Momeni P. Characteristics of frontotemporal dementia patients with a progranulin mutation. Annals of Neurology 2006, 60:374-380.
30. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Che L.K., Norton J., Morris J.C., Reed L.A., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P.R., Hayward N., Kwok J.B., Schofield P.R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B.A., Hardy J., Goate A., van Swieten J., Mann D., Lynch T., Heutink P. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705.
31. Johnston W.S., Hoskins K., McCluskey L. Amyotrophic lateral sclerosis: ethical challenges. Neurology 2011, 76:S1-S5.
32. Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Vande Velde C., Bouchard J.P., Lacomblez L., Pochigaeva K., Salachas F., Pradat P.F., Camu W., Meininger V., Dupre N., Rouleau G.A. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nature Genetics 2008, 40:572-574.
33. Kandiah N., Sengdy P., Mackenzie I.R., Hsiung G.Y., de Jesus-Hernandez M., Rademakers R. Rapidly progressive dementia in a Chinese patient due to C90RF72 mutation. The Canadian Journal of Neurological Sciences, Le Journal Canadien des Sciences Neurologiques 2012, 39:676-677.
34. Katz J.S., Katzberg H.D., Woolley S.C., Marklund S.L., Andersen P.M. Combined fulminant frontotemporal dementia and amyotrophic lateral sclerosis associated with an I113T SOD1 mutation. Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2012, 13:567-569.
35. Kaye D. Laugh. I thought I'd Die: My Life With ALS 1993, 256. Penguin Group, Canada.
36. Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet 2011, 377:942-955.
37. Kuo S., Rhodes R.L., Mitchell S.L., Mor V., Teno J.M. Natural history of feeding-tube use in nursing home residents with advanced dementia. Journal of the American Medical Directors Association 2009, 10:264-270.
38. Lechtzin N. Causes of death amongst French patients with amyotrophic lateral sclerosis: is guideline recommended care getting lost in translation?. European Journal of Neurology: the Official Journal of the European Federation of Neurological Societies 2009, 16:5-6.
39. Li S.C., Yin H.Z., Loudon W.G., Weiss J.H. Cultivating stem cells for treating amyotrophic lateral sclerosis. World Journal of Stem Cells 2012, 4:117-119.
40. Lill C.M., Abel O., Bertram L., Al-Chalabi A. Keeping up with genetic discoveries in amyotrophic lateral sclerosis: the ALSoD and ALSGene databases. Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2011, 12:238-249.
41. Ludolph A.C., Jesse S. Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials. Therapeutic Advances in Neurological Disorders 2009, 2:319-326.
42. Marzanski M. On telling the truth to patients with dementia. Western Journal of Medicine 2000, 173:318-323.
43. Marzanski M. Would you like to know what is wrong with you? On telling the truth to patients with dementia. Journal of Medical Ethics 2000, 26:108-113.
44. McCluskey L. Amyotrophic lateral sclerosis: ethical issues from diagnosis to end of life. NeuroRehabilitation 2007, 22:463-472.
45. McKenzie J.E., Herbison G.P., Roth P., Paul C. Obstacles to researching the researchers: a case study of the ethical challenges of undertaking methodological research investigating the reporting of randomised controlled trials. Trials 2010, 11:28.
46. Meininger V. Breaking bad news in amyotrophic lateral sclerosis. Palliative Medicine 1993, 7:37-40.
47. Miller B.L. The C9ORF72 mutation brings more answers and more questions. Alzheimer's Research & Therapy 2013, 5:7.
48. Miller R.G., Jackson C.E., Kasarskis E.J., England J.D., Forshew D., Johnston W., Kalra S., Katz J.S., Mitsumoto H., Rosenfeld J., Shoesmith C., Strong M.J., Woolley S.C. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009, 73:1218-1226.
49. Miller R.G., Jackson C.E., Kasarskis E.J., England J.D., Forshew D., Johnston W., Kalra S., Katz J.S., Mitsumoto H., Rosenfeld J., Shoesmith C., Strong M.J., Woolley S.C. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009, 73:1227-1233.
50. Mitsumoto H., Rabkin J.G. Palliative care for patients with amyotrophic lateral sclerosis: prepare for the worst and hope for the best. Journal of the American Medical Association 2007, 298:207-216.
51. Mitusmoto H., Rabkin J.G. Palliative care for patients with amyotrophic lateral sclerosis. Care at the Close of Life 2011, 213-230. McGraw Hill, New York. S.J. Winker, M.A. McPhee, M.W. Rabow, S.Z. Pantilat, A.J.A. Markowitz (Eds.).
52. Munroe C.A., Sirdofsky M.D., Kuru T., Anderson E.D. End-of-life decision making in 42 patients with amyotrophic lateral sclerosis. Respiratory Care 2007, 52:996-999.
53. Ng L., Khan F., Mathers S. Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database Systematic Revivew C 2009, CD007425.
54. Oliver D.J., Turner M.R. Some difficult decisions in ALS/MND. Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2010, 11:339-343.
55. Pavlovic S., Stevic Z., Milovanovic B., Milicic B., Rakocevic-Stojanovic V., Lavrnic D., Apostolski S. Impairment of cardiac autonomic control in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2010, 11:272-276.
56. Phukan J., Pender N.P., Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurology 2007, 6:994-1003.
57. Rademakers R. C9ORF72 repeat expansions in patients with ALS and FTD. Lancet Neurology 2012, 11:297-298.
58. Rademakers R., Neumann M., Mackenzie I.R. Advances in understanding the molecular basis of frontotemporal dementia. Nature Reviews Neurology 2012, 8:423-434.
59. Rosen D.R. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 364:362.
60. Schwarz J.K., Del Bene M.L. Withdrawing ventilator support for a home-based amyotrophic lateral sclerosis patient: a case study. Journal of Clinical Ethics 2004, 15:282-290.
61. Sellevold G.S., Egede-Nissen V., Jakobsen R., Sorlie V. Quality care for persons experiencing dementia: the significance of relational ethics. Nursing Ethics 2013.
62. Skoglund L., Brundin R., Olofsson T., Kalimo H., Ingvast S., Blom E.S., Giedraitis V., Ingelsson M., Lannfelt L., Basun H., Glaser A. Frontotemporal dementia in a large Swedish family is caused by a progranulin null mutation. Neurogenetics 2009, 10:27-34.
63. Smith B.N., Newhouse S., Shatunov A., Vance C., Topp S., Johnson L., Miller J., Lee Y., Troakes C., Scott K.M., Jones A., Gray I., Wright J., Hortobagyi T., Al-Sarraj S., Rogelj B., Powell J., Lupton M., Lovestone S., Sapp P.C., Weber M., Nestor P.J., Schelhaas H.J., Asbroek A.A., Silani V., Gellera C., Taroni F., Ticozzi N., Van den Berg L., Veldink J., Van Damme P., Robberecht W., Shaw P.J., Kirby J., Pall H., Morrison K.E., Morris A., de Belleroche J., Vianney de Jong J.M., Baas F., Andersen P.M., Landers J., Brown R.H., Weale M.E., Al-Chalabi A., Shaw C.E. The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder. European Journal of Human Genetics 2013, 21:102-108.
64. Snowden J.S., Harris J., Richardson A., Rollinson S., Thompson J.C., Neary D., Mann D.M., Pickering-Brown S. Frontotemporal dementia with amyotrophic lateral sclerosis: A clinical comparison of patients with and without repeat expansions in C9orf72. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2013.
65. Spataro R., Bono V., Marchese S., La Bella V. Tracheostomy mechanical ventilation in patients with amyotrophic lateral sclerosis: clinical features and survival analysis. Journal of the Neurological Sciences 2012, 323:66-70.
66. Spataro R., Lo Re M., Piccoli T., Piccoli F., La Bella V. Causes and place of death in Italian patients with amyotrophic lateral sclerosis. Acta neurologica Scandinavica 2010, 122:217-223.
67. Sproviero W., La Bella V., Mazzei R., Valentino P., Rodolico C., Simone I.L., Logroscino G., Ungaro C., Magariello A., Patitucci A., Tedeschi G., Spataro R., Condino F., Bono F., Citrigno L., Monsurro M.R., Muglia M., Gambardella A., Quattrone A., Conforti F.L. FUS mutations in sporadic amyotrophic lateral sclerosis: clinical and genetic analysis. Neurobiology of Aging 2012, 33. 837, e831-835.
68. Stavroulakis T., Walsh T., Shaw P.J., McDermott C.J., Progas S. Gastrostomy use in motor neurone disease (MND): a review, meta-analysis and survey of current practice. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2013, 14:96-104.
69. Stutzki R., Schneider U., Reiter-Theil S., Weber M. Attitudes Toward assisted suicide and life-prolonging measures in swiss als patients and their caregivers. Frontiers in Psychology 2012, 3:443.
70. Teno J.M., Gozalo P.L., Mitchell S.L., Kuo S., Rhodes R.L., Bynum J.P., Mor V. Does feeding tube insertion and its timing improve survival?. Journal of the American Geriatrics Society 2012, 60:1918-1921.
71. Tramonti F., Bongioanni P., Fanciullacci C., Rossi B. Balancing between autonomy and support: coping strategies by patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences 2012, 320:106-109.
72. Tsara V., Serasli E., Steiropoulos P., Tsorova A., Antoniadou M., Zisi P. Respiratory function in amyotrophic lateral sclerosis patients. The role of sleep studies. Hippokratia 2010, 14:33-36.
73. Turner M.R., Hardiman O., Benatar M., Brooks B.R., Chio A., de Carvalho M., Ince P.G., Lin C., Miller R.G., Mitsumoto H., Nicholson G., Ravits J., Shaw P.J., Swash M., Talbot K., Traynor B.J., Van den Berg L.H., Veldink J.H., Vucic S., Kiernan M.C. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurology 2013, 12:310-322.
74. van Blitterswijk M., Vlam L., van Es M.A., van der Pol W.L., Hennekam E.A., Dooijes D., Schelhaas H.J., van der Kooi A.J., de Visser M., Veldink J.H., van den Berg L.H. Genetic overlap between apparently sporadic motor neuron diseases. PloS ONE 2012, 7:e48983.
75. Van Hoecke A., Schoonaert L., Lemmens R., Timmers M., Staats K.A., Laird A.S., Peeters E., Philips T., Goris A., Dubois B., Andersen P.M., Al-Chalabi A., Thijs V., Turnley A.M., van Vught P.W., Veldink J.H., Hardiman O., Van Den Bosch L., Gonzalez-Perez P., Van Damme P., Brown R.H., van den Berg L.H., Robberecht W. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nature Medicine 2012, 18:1418-1422.
76. Veldink J.H., Wokke J.H., van der Wal G., Vianney de Jong J.M., van den Berg L.H. Euthanasia and physician-assisted suicide among patients with amyotrophic lateral sclerosis in the Netherlands. New England Journal of Medicine 2002, 346:1638-1644.
77. Vrijsen B., Testelmans D., Belge C., Robberecht W., Van Damme P., Buyse B. Non-invasive ventilation in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2013, 14:85-95.
78. Weber M., Eisen A., Stewart H.G., Andersen P.M. Preserved slow conducting corticomotoneuronal projections in amyotrophic lateral sclerosis with autosomal recessive D90A CuZn-superoxide dismutase mutation. Brain: a Journal of Neurology 2000, 123(Pt 7):1505-1515.
79. Wechsler I.S., Davison C. Amyotrophic lateral sclerosis with mental symptoms. Archives of Neurology and Psychiatry 1932, 27:859-880.
80. Williamson P.R., Gamble C. Identification and impact of outcome selection bias in meta-analysis. Statistics in Medicine 2005, 24:1547-1561.
81. Williamson P.R., Gamble C., Altman D.G., Hutton J.L. Outcome selection bias in meta-analysis. Statistical Methods in Medical Research 2005, 14:515-524.
82. Yang R., Huang R., Chen D., Song W., Zeng Y., Zhao B., Zhou D., Shang H.F. Causes and places of death of patients with amyotrophic lateral sclerosis in south-west China. Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2011, 12:206-209.
83. Yin F., Ye F., Tan L., Liu K., Xuan Z., Zhang J., Wang W., Zhang Y., Jiang X., Zhang D.Y. Alterations of signaling pathways in muscle tissues of patients with amyotrophic lateral sclerosis. Muscle & Nerve 2012, 46:861-870.
84. Zamietra K., Lehman E.B., Felgoise S.H., Walsh S.M., Stephens H.E., Simmons Z. Non-invasive ventilation and gastrostomy may not impact overall quality of life in patients with ALS. Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2012, 13:55-58.